Widespread genomic influences on phenotype in Dravet syndrome, a 'monogenic' condition

Brain. 2023 Sep 1;146(9):3885-3897. doi: 10.1093/brain/awad111.

Abstract

Dravet syndrome is an archetypal rare severe epilepsy, considered 'monogenic', typically caused by loss-of-function SCN1A variants. Despite a recognizable core phenotype, its marked phenotypic heterogeneity is incompletely explained by differences in the causal SCN1A variant or clinical factors. In 34 adults with SCN1A-related Dravet syndrome, we show additional genomic variation beyond SCN1A contributes to phenotype and its diversity, with an excess of rare variants in epilepsy-related genes as a set and examples of blended phenotypes, including one individual with an ultra-rare DEPDC5 variant and focal cortical dysplasia. The polygenic risk score for intelligence was lower, and for longevity, higher, in Dravet syndrome than in epilepsy controls. The causal, major-effect, SCN1A variant may need to act against a broadly compromised genomic background to generate the full Dravet syndrome phenotype, whilst genomic resilience may help to ameliorate the risk of premature mortality in adult Dravet syndrome survivors.

Keywords: SCN1A; Dravet syndrome; blended phenotypes; polygenic risk scores; polymorphism.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Epilepsies, Myoclonic* / genetics
  • Epilepsy* / genetics
  • Genomics
  • Humans
  • NAV1.1 Voltage-Gated Sodium Channel / genetics
  • Phenotype

Substances

  • NAV1.1 Voltage-Gated Sodium Channel